NDC 69168-395

Naproxen Sodium 220mg

Naproxen Sodium 220mg

Naproxen Sodium 220mg is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Allegiant Health. The primary component is Naproxen Sodium.

Product ID69168-395_7839ce0e-accf-4fbd-8225-05097d7410c0
NDC69168-395
Product TypeHuman Otc Drug
Proprietary NameNaproxen Sodium 220mg
Generic NameNaproxen Sodium 220mg
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2011-05-04
Marketing CategoryANDA /
Application NumberANDA090545
Labeler NameAllegiant Health
Substance NameNAPROXEN SODIUM
Active Ingredient Strength220 mg/1
Pharm ClassesAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69168-395-17

300 TABLET, COATED in 1 BOTTLE (69168-395-17)
Marketing Start Date2021-04-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Naproxen Sodium 220mg" or generic name "Naproxen Sodium 220mg"

NDCBrand NameGeneric Name
53185-362Naproxen Sodium 220mgNaproxen Sodium 220mg
53185-394Naproxen Sodium 220mgNaproxen Sodium 220mg
53329-678Naproxen Sodium 220mgNaproxen Sodium
53329-688Naproxen Sodium 220mgNaproxen Sodium
69168-395Naproxen Sodium 220mgNaproxen Sodium 220mg
69197-394Naproxen Sodium 220mgNaproxen Sodium 220mg
69168-632Naproxen SodiumNaproxen Sodium 220mg

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.